Systematic Financial Management LP Sells 68,967 Shares of Perrigo Company plc $PRGO

Systematic Financial Management LP cut its holdings in Perrigo Company plc (NYSE:PRGO) by 5.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,260,959 shares of the company’s stock after selling 68,967 shares during the period. Systematic Financial Management LP’s holdings in Perrigo were worth $17,553,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Amundi grew its stake in shares of Perrigo by 11.7% in the 1st quarter. Amundi now owns 5,292 shares of the company’s stock valued at $148,000 after buying an additional 556 shares during the period. Kestra Investment Management LLC grew its stake in shares of Perrigo by 57.1% in the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock valued at $47,000 after buying an additional 642 shares during the period. State of Wyoming grew its stake in shares of Perrigo by 7.8% in the 3rd quarter. State of Wyoming now owns 8,988 shares of the company’s stock valued at $200,000 after buying an additional 653 shares during the period. First Citizens Bank & Trust Co. grew its stake in shares of Perrigo by 4.7% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 17,323 shares of the company’s stock valued at $386,000 after buying an additional 775 shares during the period. Finally, Geneos Wealth Management Inc. grew its stake in shares of Perrigo by 439.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after buying an additional 786 shares during the period. 95.91% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on PRGO shares. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Canaccord Genuity Group reduced their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research note on Friday, February 27th. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Weiss Ratings upgraded Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 13th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $19.33.

Perrigo Price Performance

PRGO stock opened at $11.21 on Friday. The company has a market capitalization of $1.55 billion, a P/E ratio of -0.86, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.59 and a current ratio of 2.72. Perrigo Company plc has a 52-week low of $9.23 and a 52-week high of $28.43. The business has a 50-day simple moving average of $10.83 and a two-hundred day simple moving average of $12.84.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. The business had revenue of $841.80 million during the quarter, compared to the consensus estimate of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The company’s quarterly revenue was down 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Research analysts expect that Perrigo Company plc will post 2.14 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, May 29th. This represents a $1.16 dividend on an annualized basis and a yield of 10.4%. Perrigo’s payout ratio is -8.85%.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.